Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix and Perlegen Join to Offer Genotyping Service

NEW YORK, July 6 (GenomeWeb News) - Affymetrix and Perlegen Sciences will jointly offer a custom genotyping service, the companies said today.


Under the agreement, Affymetrix will market the service to customers, while Perlegen will analyze customer samples using its high-throughput genotyping technology.


The service will cover projects ranging from several thousand to 50,000 SNPs in up to several thousand samples. Perlegen's genotyping system is based on Affymetrix's microarray technology.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.